results|interferon|subj
results|remission|in
remission|about 20 percent|in
about 20 percent|cases|of
1.8 percent|only|mod
patients|zeffix-treated|mod
1.8 percent|patients|of
progressed|1.8 percent|subj
progressed|cirrhosis|to
cirrhosis|compared|vrel
compared|cirrhosis|obj
patients|7.1 percent|nn
patients|placebo-treated|mod
compared|patients|with
patients|and|punc
patients|9.5 percent|conj
9.5 percent|those|of
those|treated|vrel
treated|those|obj
treated|interferon-alpha|with
b|chronic|mod
b|hepatitis|nn
therapies|b|for
were|limited|pred
limited|interferons|to
interferons|which|whn
injected|interferons|obj
injected|and|punc
injected|lead to|conj
lead to|interferons|subj
effects|unpleasant|mod
effects|side|nn
lead to|effects|obj
gratified|doctors|obj
see|doctor|subj
see|that|c
progressed|interferon|as
progressed|treatment|subj
shrank|tumor|subj
levels|jennifer|gen
levels|blood|nn
levels|fgf|of
gratified|fell|fc
fell|levels|subj
treatment|standard|mod
interferon|drug|nn
is|interferon|pred
interferon|or|punc
interferon|combination|conj
combination|interferon|of
interferon|and|punc
interferon|ribavirin|conj
giving|patients|obj
called|drug|subj
beta-1a|interferon|nn
called|beta-1a|obj
beta-1a|weeks|within
inflammation|first|post
inflammation|nerve|nn
beta-1a|inflammation|of
inflammation|cut|vrel
cut|inflammation|obj1
cut|likelihood|obj2
likelihood|developing|of
developing|drug|subj
symptoms|ms|nn
developing|symptoms|obj
years|three|amount-value
symptoms|years|within
years|44 percent|by
rebetron|made|vrel
made|rebetron|obj
made|by|by-subj
made|schering-plough corp.|by
approved|rebetron|obj
approved|june|in
june|only|pnmod
only|patients|for
patients|who|whn
relapsed|patients|subj
taking|rebetron|subj
drugs|interferon|nn
taking|drugs|obj
other|only|mod
treatment|other|mod
treatment|approved|mod
drugs|treatment|appo
treatment|disease|for
said|di bisceglie|subj
interferon|antiviral|mod
interferon|drug|nn
said|reduced|fc
reduced|interferon|subj
reduced|symptoms|obj
20|up to|num-mod
symptoms|20|in
c|hepatitis|nn
patients|c|with
c|who|whn
treated|c|obj
months|six|amount-value
treated|months|for
specialized pharmacy services|fisher|gen
specialized pharmacy services|pittsburgh|in
announced|specialized pharmacy services|subj
announced|plans|obj
plans|fill|comp1
fill|specialized pharmacy services|subj
fill|prescriptions|obj
prescriptions|nationwide|pnmod
ribavirin|anti-viral|mod
ribavirin|drug|nn
nationwide|ribavirin|for
ribavirin|used|vrel
used|ribavirin|obj
used|by|by-subj
numbers|growing|mod
used|numbers|by
patients|hepatitis|nn
patients|c|nn
numbers|patients|of
patients|combination|in
interferon|drug|nn
combination|interferon|with
journal|thursday|gen
journal|new england|nn
study|journal|in
journal|medicine|of
looked at|study|subj
looked at|effects|obj
3tc|drug|nn
effects|3tc|of
3tc|people|on
infections|long-standing|mod
people|infections|with
infections|virus|with
cause|leading|mod
is|cause|pred
disease|chronic|mod
disease|liver|nn
cause|disease|of
food and drug administration|wednesday|on
approved|food and drug administration|subj
combination|powerful|mod
approved|combination|obj
